Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Laboratory Investigation

• Publication date

  2012-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/labinvest.2012.75PMID 22525431
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of the Inducible Nitric Oxide Synthase in the Onset of Fructose-Induced Steatosis in Mice

  2011cited by this paper
• Fructose-induced steatosis in mice: role of plasminogen activator inhibitor-1, microsomal triglyceride transfer protein and NKT cells

  2011cited by this paper
• Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice.

  2011cited by this paper
• Endotoxin and Plasminogen Activator Inhibitor-1 Serum Levels Associated With Nonalcoholic Steatohepatitis in Children

  2010cited by this paper
• Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study

  2010cited by this paper
• Effect of Obesity on Growth‐related Oncogene Factor‐α, Thrombopoietin, and Tissue Inhibitor Metalloproteinase‐1 Serum Levels

  2010cited by this paper
• Effects of Metformin and Weight Loss on Serum Alanine Aminotransferase Activity in the Diabetes Prevention Program

  2010cited by this paper
• Metalloproteinase mediated occludin cleavage in the cerebral microcapillary endothelium under pathological conditions.

  2010cited by this paper
• Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazone.

  2010cited by this paper
• Protective effect of bile acids on the onset of fructose-induced hepatic steatosis in mice

  2010cited by this paper
• Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease

  2009cited by this paper
• Therapy of nonalcoholic fatty liver disease: current status.

  2009cited by this paper
• Dietary fructose and intestinal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease.

  2009cited by this paper
• Toll‐like receptor 4 is involved in the development of fructose‐induced hepatic steatosis in mice

  2009cited by this paper
• Treatment of non‐alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin‐resistant adolescents

  2009cited by this paper
• Diabetes of the Liver: The Link Between Nonalcoholic Fatty Liver Disease and HFCS‐55

  2009cited by this paper
• Disruptions of occludin and claudin‐5 in brain endothelial cells in vitro and in brains of mice with acute liver failure

  2009cited by this paper
• Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes.

  2008cited by this paper
• High Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Morbid Obesity: A Contributor to Severe Hepatic Steatosis

  2008cited by this paper
• Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake.

  2008cited by this paper
• Fructose consumption as a risk factor for non-alcoholic fatty liver disease.

  2008cited by this paper
• Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice

  2008cited by this paper
• Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin.

  2008cited by this paper
• Metformin Prevents Endotoxin-Induced Liver Injury after Partial Hepatectomy

  2006cited by this paper
• Metformin prevents alcohol-induced liver injury in the mouse: Critical role of plasminogen activator inhibitor-1.

  2006cited by this paper
• Consuming fructose-sweetened beverages increases body adiposity in mice.

  2005cited by this paper
• Thymosin alpha 1 attenuates lipid peroxidation and improves fructose-induced steatohepatitis in rats.

  2005cited by this paper
• Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study

  2005cited by this paper
• Fructose-Induced Fatty Liver Disease: Hepatic Effects of Blood Pressure and Plasma Triglyceride Reduction

  2005cited by this paper
• Divergent roles for p55 and p75 TNF-alpha receptors in the induction of plasminogen activator inhibitor-1.

  2003cited by this paper
• Comparison of the metabolic effects of metformin and troglitazone on fructose-induced insulin resistance in male Sprague-Dawley rats.

  2001cited by this paper
• Disrupted signaling and inhibited regeneration in obese mice with fatty livers: Implications for nonalcoholic fatty liver disease pathophysiology

  2001cited by this paper
• Metformin reverses fatty liver disease in obese, leptin-deficient mice

  2000cited by this paper
• Metformin Causes a Reduction in Basal and Post‐venous Occlusion Plasminogen Activator Inhibitor‐1 in Type 2 Diabetic Patients

  1991cited by this paper

• TNFα is a trigger of aging-associated liver inflammation in mice

  2026cites this paper
• Toll-like receptor 2 drives liver senescence and fibrosis in aging through gut-derived microbial signaling.

  2026cites this paper
• Aging-related decline in the liver and brain is accelerated by refined diet consumption.

  2025cites this paper
• The impact of high-sugar diets on central nervous system disorders: mechanisms, pathogenesis, and dietary implication

  2025cites this paper
• Effects of Fructose on Features of Steatotic Liver Disease in HepG2 Cells

  2025cites this paper
• Impact of Fructose-Enhanced Solid and Soft Drink Diets on Metabolism, Physiology, and Gut Microbiome in Pregnant Rats

  2025cites this paper
• Early-onset colorectal cancer as an emerging disease of metabolic dysregulation

  2025cites this paper
• Hernandezine alleviates inflammatory bowel disease by enhancing gut barrier integrity via the AMPK/NRF2 pathway and regulating immune-metabolic balance.

  2025cites this paper
• Calcitriol/Vitamin D Receptor Ameliorates Fructose-Induced Enteritis-Hepatitis Axis Dysregulation in Mice.

  2025cites this paper
• Metabolic dysfunction–associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovations

  2025cites this paper
• Fructose catabolism and its metabolic effects: Exploring host–microbiota interactions and the impact of ethnicity

  2025cites this paper
• Metformin's modulation of gut microbiota and its implications for Non-Alcoholic Fatty Liver Disease(NAFLD): A network pharmacology and molecular dynamics study

  2025cites this paper
• Diet-Induced Gut Dysbiosis and Leaky Gut Syndrome

  2024cites this paper
• Use of an electrical stimulation-induced fatigue protocol to evaluate the myotropic effects of metabolic-active agents in db/db mice

  2024cites this paper
• Oral supplementation of choline attenuates the development of alcohol-related liver disease (ALD)

  2024cites this paper
• Regulation of Fructose Metabolism in Nonalcoholic Fatty Liver Disease

  2024cites this paper
• The Importance of Maintaining and Improving a Healthy Gut Microbiota in Athletes as a Preventive Strategy to Improve Heat Tolerance and Acclimatization

  2024cites this paper
• The relevance of intestinal barrier dysfunction, antimicrobial proteins and bacterial endotoxin in metabolic dysfunction‐associated steatotic liver disease

  2024cites this paper
• Bile acids mediate fructose-associated liver tumour growth in mice.

  2024cites this paper
• Oral Supplementation of Phosphatidylcholine Attenuates the Onset of a Diet-Induced Metabolic Dysfunction–Associated Steatohepatitis in Female C57BL/6J Mice

  2024cites this paper
• Detection and Quantification of Some Ethanol-Producing Bacterial Strains in the Gut of Mouse Model of Non-Alcoholic Fatty Liver Disease: Role of Metformin

  2023influential citation
• Supplementing L-Citrulline Can Extend Lifespan in C. elegans and Attenuate the Development of Aging-Related Impairments of Glucose Tolerance and Intestinal Barrier in Mice

  2023influential citation
• Antibiotics attenuate diet-induced non-alcoholic fatty liver disease without altering intestinal barrier dysfunction.

  2023cites this paper
• Human α-Defensin 51–9 and Human β-Defensin 2 Improve Metabolic Parameters and Gut Barrier Function in Mice Fed a Western-Style Diet

  2023cites this paper
• TNFα is a key trigger of inflammation in diet-induced non-obese MASLD in mice

  2023cites this paper
• Comparing the Influences of Metformin and Berberine on the Intestinal Microbiota of Rats With Nonalcoholic Steatohepatitis

  2023cites this paper
• Cognitive Alterations in Old Mice Are Associated with Intestinal Barrier Dysfunction and Induced Toll-like Receptor 2 and 4 Signaling in Different Brain Regions

  2023cites this paper
• Fructose: a modulator of intestinal barrier function and hepatic health?

  2023cites this paper
• The impact of dietary fructose on gut permeability, microbiota, abdominal adiposity, insulin signaling and reproductive function

  2023cites this paper
• Efficacy of pectins with different degrees of methyl-esterification and of blockiness in preventing gut epithelial cell barrier disruption and the impact on sodium-glucose co-transporter expression under low and high glucose conditions.

  2023cites this paper
• “Metformin Impairs Intestinal Fructose Metabolism”

  2023cites this paper
• Correlation between long-term use of metformin and incidence of NAFLD among patients with type 2 diabetes mellitus: A real-world cohort study

  2022cites this paper
• Effects of metformin and simvastatin treatment on ultrastructural features of liver macrophages in HFD mice

  2022cites this paper
• LETROZOLE SUPPRESSES HEPATIC OXIDATIVE STRESS AND AMELIORATES LIPID ACCUMULATION IN FRUCTOSE-EXPOSED WISTER RATS

  2022cites this paper
• Impairments of intestinal arginine and NO metabolisms trigger aging-associated intestinal barrier dysfunction and ‘inflammaging'

  2022cites this paper
• Novel dual PPARα/γ agonists protect against liver steatosis and improve insulin sensitivity while avoiding side effects.

  2022cites this paper
• Fructose, a trigger of metabolic diseases?—a narrative review

  2022cites this paper
• Wheat alkylresorcinol increases fecal lipid excretion and suppresses feed efficiency in mice depending on time of supplementation.

  2022cites this paper
• Celecoxib attenuates hepatosteatosis by impairing de novo lipogenesis via Akt‐dependent lipogenic pathway

  2022cites this paper
• Considering Intestinal Hyperpermeability and Immune-Inflammatory Metabolism in the Treatment of Food Allergy

  2022cites this paper
• Are fructophilic lactic acid bacteria (FLAB) beneficial to humans?

  2022cites this paper
• Glucose but Not Fructose Alters the Intestinal Paracellular Permeability in Association With Gut Inflammation and Dysbiosis in Mice

  2021cites this paper
• "Sweet death": Fructose as a metabolic toxin that targets the gut-liver axis.

  2021cites this paper
• Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease

  2021cites this paper
• Gut and liver metabolic responses to dietary fructose - are they reversible or persistent after switching to a healthy diet?

  2021cites this paper
• Centennial Review: Recent developments in host-pathogen interactions during necrotic enteritis in poultry

  2021cites this paper
• Sugar Fructose Triggers Gut Dysbiosis and Metabolic Inflammation with Cardiac Arrhythmogenesis

  2021cites this paper
• Fructose Causes Liver Damage, Polyploidy, and Dysplasia in the Setting of Short Telomeres and p53 Loss

  2021cites this paper
• Potential mechanistic pathways underlying intestinal and hepatic effects of kefir in high-fructose-fed rats.

  2021cites this paper
• The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New Insights

  2021cites this paper
• Microbiota profiling in aging-associated inflammation and liver degeneration.

  2021cites this paper
• Fortifying Butterfat with Soybean Oil Attenuates the Onset of Diet-Induced Non-Alcoholic Steatohepatitis and Glucose Intolerance

  2021cites this paper
• Citrulline supplementation attenuates the development of non-alcoholic steatohepatitis in female mice through mechanisms involving intestinal arginase

  2021cites this paper
• Plumericin Protects against Experimental Inflammatory Bowel Disease by Restoring Intestinal Barrier Function and Reducing Apoptosis

  2021cites this paper
• Aging-related liver degeneration is associated with increased bacterial endotoxin and lipopolysaccharide binding protein levels.

  2020cites this paper
• Effect of High-Dose Metformin on the Metabolic Parameters and Functional State of the Liver of Agouti Mice with Melanocortin Obesity

  2020cites this paper
• Intestinal fructose absorption: Modulation and relation to human diseases

  2020cites this paper
• Excess dietary fructose does not alter gut microbiota or permeability in humans: A randomized controlled pilot study

  2020cites this paper
• Roles of AMP-Activated Protein Kinase (AMPK) in Mammalian Reproduction

  2020cites this paper
• Dietary Carbohydrates and Lipids in the Pathogenesis of Leaky Gut Syndrome: An Overview

  2020cites this paper
• Effects of Dietary Components on Intestinal Permeability in Health and Disease.

  2020cites this paper
• Exchanging dietary fat source with extra virgin olive oil does not prevent progression of diet-induced non-alcoholic fatty liver disease and insulin resistance

  2020cites this paper
• Sex-Specific Associations of Trimethylamine-N-Oxide and Zonulin with Signs of Depression in Carbohydrate Malabsorbers and Nonmalabsorbers

  2020cites this paper
• Fructose stimulated de novo lipogenesis is promoted by inflammation

  2020cites this paper
• Fortifying diet with rapeseed oil instead of butterfat attenuates the progression of diet-induced non-alcoholic fatty liver disease (NAFLD) and impairment of glucose tolerance.

  2020cites this paper
• A Sweet Connection? Fructose’s Role in Hepatocellular Carcinoma

  2020cites this paper
• The FiberTAG project: Tagging dietary fibre intake by measuring biomarkers related to the gut microbiota and their interest for health

  2020cites this paper
• Fructose and irritable bowel syndrome

  2020cites this paper
• Reversion of down-regulation of intestinal multidrug resistance-associated protein 2 in fructose-fed rats by geraniol and vitamin C: Potential role of inflammatory response and oxidative stress.

  2019cites this paper
• Obesity and Metabolic Syndrome in Kidney Transplantation: The Role of Dietary Fructose and Systemic Endotoxemia

  2019cites this paper
• Short‐Term Isocaloric Intake of a Fructose‐ but not Glucose‐Rich Diet Affects Bacterial Endotoxin Concentrations and Markers of Metabolic Health in Normal Weight Healthy Subjects

  2019cites this paper
• Metformin prevents colonic barrier dysfunction by inhibiting mast cell activation in maternal separation‐induced IBS‐like rats

  2019cites this paper
• Moderate consumption of fermented alcoholic beverages diminishes diet-induced non-alcoholic fatty liver disease through mechanisms involving hepatic adiponectin signaling in mice

  2019cites this paper
• Influence of the Maillard-type caseinate glycation with lactose on the intestinal barrier activity of the caseinate digest in IEC-6 cells.

  2019cites this paper
• Managing Metabolic Health Impact of Fructose-Containing Beverages

  2019cites this paper
• Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine

  2019cites this paper
• The PPAR–microbiota–metabolic organ trilogy to fine‐tune physiology

  2019cites this paper
• A new method to induce nonalcoholic steatohepatitis (NASH) in mice

  2019cites this paper
• Effect of chrysin on changes in intestinal environment and microbiome induced by fructose-feeding in rats.

  2019cites this paper
• Therapeutic effect of treatment with metformin and/or 4-hydroxychalcone in male Wistar rats with nonalcoholic fatty liver disease.

  2019cites this paper
• Biomarkers of leaky gut are related to inflammation and reduced physical function in older adults with cardiometabolic disease and mobility limitations

  2019cites this paper
• Reciprocal Association between the Apical Junctional Complex and AMPK: A Promising Therapeutic Target for Epithelial/Endothelial Barrier Function?

  2019cites this paper
• Mechanisms linking mechanotransduction and cell metabolism.

  2018cites this paper
• Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function

  2018cites this paper
• An iso-α-acid-rich extract from hops (Humulus lupulus) attenuates acute alcohol-induced liver steatosis in mice.

  2018cites this paper
• Intestinal Microbial and Metabolite Profiling of Mice Fed with Dietary Glucose and Fructose

  2018cites this paper
• Short-term treatment with metformin reduces hepatic lipid accumulation but induces liver inflammation in obese mice

  2018cites this paper
• Microbiome and Diseases: Hepatic Disorders

  2018cites this paper
• A high‑fructose diet induces epithelial barrier dysfunction and exacerbates the severity of dextran sulfate sodium‑induced colitis.

  2018cites this paper
• The Eeffect of Metformin Combined with Calcium-Vitamin D3 Against Diet-Induced Nonalcoholic Fatty Liver Disease

  2018cites this paper
• Short-term treatment with metformin reduces hepatic lipid accumulation but induces liver inflammation in obese mice

  2018cites this paper
• Natural products, an important resource for discovery of multitarget drugs and functional food for regulation of hepatic glucose metabolism

  2018cites this paper
• Intestinal plasticity in response to nutrition and gastrointestinal surgery

  2018cites this paper
• AMPK in regulation of apical junctions and barrier function of intestinal epithelium

  2018cites this paper
• Adipocytokine Regulation and Antiangiogenic Activity Underlie the Molecular Mechanisms of Therapeutic Effects of Phyllanthus niruri against Non-Alcoholic Fatty Liver Disease

  2018cites this paper
• Oral administration of fructose exacerbates liver fibrosis and hepatocarcinogenesis via increased intestinal permeability in a rat steatohepatitis model

  2018cites this paper
• Metformin Protects against LPS-Induced Intestinal Barrier Dysfunction by Activating AMPK Pathway.

  2018cites this paper
• Lack of liver steatosis in germ-free mice following hypercaloric diets

  2018cites this paper
• Intestinal Microbial and Metabolic Profiling of Mice Fed with High-Glucose and High-Fructose Diets.

  2018cites this paper
• Prebiotics Reduce Body Fat and Alter Intestinal Microbiota in Children Who Are Overweight or With Obesity.

  2017cites this paper